Voyager Therapeutics, Inc.’s Post

Voyager’s Kumar Dhanasekharan is presenting about successful implementation of large scale manufacturing of novel capsids with complex payloads at this week’s 8th Annual Gene Therapy Development Summit. He’ll also take part in a panel discussion “Navigating the Complex Supply Chain for Gene Therapies.” Learn more about the conference: https://bit.ly/4j0XPbw

  • Voyager's SVP of Technical Operations Kumar Dhanasekharan will attend the Gene Therapy Development Summit from March 25-27, 2025 in Boston.
Suresh Ramu

Co-founder & CEO at Cytecare Hospitals

3w

Great to see this Kumar Dhanasekharan

See more comments

To view or add a comment, sign in

Explore topics